# nelarabine

NDC: 81927-375
Generic name: nelarabine
Labeler / Manufacturer: Shorla Oncology Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250831

FDA application: ANDA214809

## Active ingredients

- NELARABINE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81927-375"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81927-375
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc401b06-4e3b-413e-a854-3e031c433862